<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469519</url>
  </required_header>
  <id_info>
    <org_study_id>OBX0034</org_study_id>
    <nct_id>NCT02469519</nct_id>
  </id_info>
  <brief_title>Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes</brief_title>
  <acronym>ACSinPROM</acronym>
  <official_title>A Randomized Double-blinded Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids on Neonatal Outcome in the Patient With Prelabor Premature Rupture of the Membranes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mednax Center for Research, Education, Quality and Safety</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mednax Center for Research, Education, Quality and Safety</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial hopes to prospectively evaluate the impact of one versus two courses of antenatal
      steroids on the incidence of major neonatal morbidity in pregnant women with pre-labor
      premature rupture of the membranes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter randomized double blinded trial that hopes to prospectively evaluate
      the impact of one versus two courses of antenatal steroids on the incidence of major neonatal
      morbidity including respiratory distress syndrome in pregnant women with a singleton
      gestation between 24w0d - 32w6d gestation who have documented premature rupture of the
      membranes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Neonatal Morbidity</measure>
    <time_frame>from birth through the first 28 days of life</time_frame>
    <description>Composite Neonatal Morbidity includes any one or more of the following: respiratory distress syndrome, bronchopulmonary dysplasia, severe intraventricular hemorrhage, periventricular leukomalacia, proven sepsis, necrotizing enterocolitis, or neonatal death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational age of baby</measure>
    <time_frame>measured within the first 24 hours following birth.</time_frame>
    <description>gestational age of the baby on the day of it's birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baby's birth weight</measure>
    <time_frame>measured within the first 24 hours following birth</time_frame>
    <description>weight of the baby taken with in the first hours following birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intrauterine growth restriction (IUGR)</measure>
    <time_frame>anytime during the pregnancy prior to birth (~ 9 months of pregnancy)</time_frame>
    <description>a measurement done by ultrasound taken at any time during the pregnancy prior to birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baby's Head Circumference</measure>
    <time_frame>measured within the first 24 hours following birth</time_frame>
    <description>a measurement of the baby's head taken within the first hours following birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newborn Mechanical Ventilatory days</measure>
    <time_frame>measured from birth to 28 days following birth</time_frame>
    <description>measurement of the total number of days the baby requires mechanical ventilatory support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newborn Oxygen support days</measure>
    <time_frame>measured from birth to 28 days following birth</time_frame>
    <description>measurement of the total number of days the baby requires oxygen support (example: nasal cannula, CPAP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newborn Surfactant therapy</measure>
    <time_frame>measured within the first 24 hours following birth</time_frame>
    <description>measurement of the need for newborn surfactant therapy within the first 28 day following birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newborn Hospital Days</measure>
    <time_frame>measured within the first 24 hours following birth</time_frame>
    <description>the number of days that newborn remains in the hospital following its birth.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumothorax</measure>
    <time_frame>measured within the first 24 hours following birth</time_frame>
    <description>diagnosis of a collapsed lung supported by clinical or radiologic evidence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Infectious Morbidity</measure>
    <time_frame>measured within the first 24 hours following birth</time_frame>
    <description>diagnosis of maternal infection for example; chorioamnionitis, endometritis or postoperative wound infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time from first dose of study drug to birth</measure>
    <time_frame>measured in days/hours from the time of administration of first study drug until birth.</time_frame>
    <description>the number of hours/days from the time of the first dose of study drug until birth</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">142</enrollment>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>Betamethasone - ACTIVE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Booster Course of Antenatal Steroids consists of Betamethasone [12 mg intramuscular injection, 24 hours apart X 2 doses] or if unavailable may give Dexamethasone [6 mg intramuscularly 12 hours apart x 4 doses]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline - PLACEBO</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline of equivalent volume given intramuscularly at the equivalent dosing regimes listed in experimental arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Betamethasone - ACTIVE</intervention_name>
    <description>antenatal corticosteroid (ACS) is to be given by injection 24 hours apart for two doses.</description>
    <arm_group_label>Betamethasone - ACTIVE</arm_group_label>
    <other_name>antenatal corticosteroid</other_name>
    <other_name>dexamethasone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline - PLACEBO</intervention_name>
    <description>normal saline of the same quantity as with the experimental drug is to be given by injection 24 hours apart for two doses</description>
    <arm_group_label>normal saline - PLACEBO</arm_group_label>
    <other_name>NS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants age 18 years or older

          -  24w0d to 32w6d weeks gestation

          -  Singleton pregnancy

          -  Received first course of ACS at or prior to 31w6d gestation

          -  Began first course of ACS at least 7 days ( =/&gt; 168 hours) prior to randomization

          -  Expectant management planned

          -  Premature Ruptured membranes (PROM) before onset of labor

        Exclusion Criteria:

          -  Known major fetal anomalies

          -  Multiple gestation

          -  Not a candidate for expectant management

          -  Clinical chorioamnionitis (two or more of the following: temperature &gt; 38.0 degrees
             centigrade; uterine tenderness; foul smelling vaginal discharge or amniotic fluid;
             maternal tachycardia &gt;100 bpm; fetal tachycardia &gt;160 bpm; maternal White Blood Cell
             (WBC) count &gt;20 X 109/L; C-Reactive Protein (CRP) &gt; 5.9

          -  Already receiving corticosteroids for another condition

          -  Any contraindications to the maternal use of corticosteroids
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas J Garite, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mednax Center for Research, Education, Quality and Safety</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Porreco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mednax Center for Research, Education, Quality and Safety</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly Maurel, MSN</last_name>
    <phone>7145939171</phone>
    <email>kimberly_maurel@mednax.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Barbara Marusiak, RN</last_name>
    <phone>480-949-5997</phone>
    <email>barbara_marusiak@mednax.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of South Alabama Medical Center</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36617</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Brocato, MD</last_name>
      <phone>251-415-1598</phone>
      <email>brianbrocato@usouthal.edu</email>
    </contact>
    <contact_backup>
      <last_name>Casey Armestead</last_name>
      <phone>251-415-1598</phone>
      <email>marmestead@usouthal.edu</email>
    </contact_backup>
    <investigator>
      <last_name>brian brocato, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenix Perinatal Associates</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Bodea-Braescu, MSN, MPH</last_name>
      <phone>602-614-0488</phone>
      <email>ana_braescu@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Kevin Huls, MD</last_name>
      <phone>480-969-5999</phone>
      <email>kevin_huls@mednax.com</email>
    </contact_backup>
    <investigator>
      <last_name>Kevin Huls, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90801-1428</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Nageotte, MD</last_name>
      <phone>562-933-2730</phone>
      <email>Michael_nageotte@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Deysi Caballero, LVN</last_name>
      <phone>562-933-2730</phone>
      <email>dcaballero@memorialcare.org</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Nageotte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Combs, MD</last_name>
      <phone>408-371-7111</phone>
      <email>andrew_combs@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Kimberly Mallory, RN</last_name>
      <phone>408-371-7111</phone>
      <email>kimberly_mallory@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Combs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presbyterian/St Luke's Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Porreco, MD</last_name>
      <phone>303-860-9990</phone>
      <email>richard_porreco@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Julie Rael, RN</last_name>
      <phone>303-570-8138</phone>
      <email>julie_rael@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Richard Porreco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Servay, RN</last_name>
      <phone>504-894-3039</phone>
      <email>cservay@ochsner.org</email>
    </contact>
    <contact_backup>
      <last_name>Sherri Longo, MD</last_name>
      <phone>504-842-4151</phone>
      <email>slongo@ochsner.org</email>
    </contact_backup>
    <investigator>
      <last_name>Sherri Longo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lousiana State University Health Science</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Lewis, MD</last_name>
      <phone>318-675-5379</phone>
      <email>dlewis@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>David Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Weitz</last_name>
      <phone>865-544-8888</phone>
      <email>BWeitz@utmck.edu</email>
    </contact>
    <investigator>
      <last_name>Craig Towers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harris Methodist Hospital - Fort Worth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122-4307</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lan Tran, MD</last_name>
      <phone>206-624-7730</phone>
      <email>lan_tran@mednax.com</email>
    </contact>
    <contact_backup>
      <last_name>Dawn Artis, RN</last_name>
      <phone>206-954-9617</phone>
      <email>dawn_artis@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Lan Tran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2015</study_first_submitted>
  <study_first_submitted_qc>June 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2015</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

